數位呼吸市場規模、佔有率和成長分析：按產品類型、技術、適應症、銷售管道和地區分類－2026-2033年產業預測

2024 年全球數位呼吸設備市場價值為 188 億美元，預計到 2025 年將成長至 203.4 億美元，到 2033 年將成長至 382.1 億美元，預測期（2026-2033 年）複合年成長率為 8.2%。

全球數位呼吸設備市場涵蓋連網吸入器、智慧霧化器、穿戴式肺計量計和遠端監測平台，其成長主要受慢性呼吸系統疾病盛行率上升以及感測器技術和雲端分析技術進步的推動。該領域在減少住院率、提高患者用藥依從性以及為醫療服務提供者和保險公司產生寶貴數據方面發揮著至關重要的作用。從基礎峰值流量計到高度整合的系統，在遠端照護的支持下，其發展已被證明能夠有效改善慢性阻塞性肺病（COPD）和氣喘等疾病的治療效果。推動市場成長的關鍵因素包括保險公司對報銷框架內數位監測的認知度提高、數位監測與臨床工作流程的整合，以及利用人工智慧進行預測分析和預防性患者管理的創新試點計畫的推進，所有這些最終都將帶來成本節約和更好的健康結果。

全球數位呼吸設備市場的成長要素

全球數位呼吸設備市場正經歷顯著成長，這主要得益於互聯技術的進步，這些技術實現了遠端患者監護、數據採集以及與臨床工作流程的無縫整合。這些創新提高了感測器精度和無線連接性能，增強了患者依從性，並透過預防性管理慢性呼吸系統疾病，減少了間歇性治療的需求。製造商正利用這些進步創造增值服務，並加強與遠端醫療平台的合作。這不僅擴大了市場覆蓋範圍，也刺激了各醫療機構對產品創新和商業化的投資。這一上升趨勢對整體市場擴張至關重要。

全球數位呼吸設備市場的限制因素

全球數位呼吸機市場面臨許多挑戰，主要源自於各地區複雜多元的監管要求。這些法規可能阻礙產品開發和市場准入，最終限制產業成長。製造商通常需要投入大量資源來收集臨床證據、遵守設備和軟體標準，並解決網路安全和資料隱私問題，這可能導致開發週期延長和不確定性。因此，中小企業可能會選擇延後產品上市或限制目標市場，以減輕合規負擔。同時，醫療系統和保險公司在未獲得明確核准的情況下，可能不願採用新技術，這進一步延緩了數位呼吸器相關創新技術惠及更廣泛患者群體的進程。

全球數位呼吸設備市場趨勢

全球數位呼吸設備市場正經歷著向家庭互聯和遠端監測解決方案的顯著轉變。隨著遠端控制呼吸設備的普及，在傳統臨床環境之外病患監測將成為可能，使臨床醫生能夠即時有效地追蹤患者的症狀、用藥依從性和環境因素。與家庭網路、智慧型手機和雲端技術的整合將有助於實現預防性患者照護，從而改善治療效果並減少醫療服務的碎片化。消費者對直覺的使用者介面和安全的資料共用功能的需求日益成長，迫使製造商更加重視互通性和易用性。因此，護理模式正朝著預防性和以家庭為中心的管理方向發展，促進患者與醫療服務提供者之間更緊密的合作，並推動呼吸系統護理服務的公平獲取。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球數位呼吸器市場規模：依產品類型分類

• 智慧吸入器
• 數位肺計量計
• 穿戴式呼吸監測器
• 數位式峰值流量計
• 數位脈搏血氧飽和度分析儀

全球數位呼吸器市場規模：按技術分類

• 支援藍牙的設備
• Wi-Fi 連線裝置

全球數位呼吸器市場規模：依適應症分類

• 氣喘
• 慢性阻塞性肺病
• 睡眠呼吸中止症
• 其他

全球數位呼吸器市場規模：按銷售管道分類

• 醫院採購
• 零售藥房
• 線上零售
• 其他

全球數位呼吸器市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Koninklijke Philips
• Medtronic
• ResMed
• Fisher & Paykel Healthcare
• Dragerwerk
• Propeller Health
• Adherium
• Cohero Health
• Aptar Pharma
• Novartis
• GlaxoSmithKline（GSK）
• Boehringer Ingelheim
• AstraZeneca
• Teva Pharmaceuticals
• Viatris
• OMRON Healthcare
• Getinge
• Hamilton Medical
• Smiths Medical
• Invacare

結論與建議

Global Digital Respiratory Devices Market size was valued at USD 18.8 Billion in 2024 and is poised to grow from USD 20.34 Billion in 2025 to USD 38.21 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global digital respiratory devices market, comprising connected inhalers, smart nebulizers, wearable spirometers, and remote monitoring platforms, is propelled by the rising prevalence of chronic respiratory diseases alongside advancements in sensor technology and cloud analytics. This sector plays a crucial role in reducing hospitalizations, enhancing patient adherence, and generating insightful data for healthcare providers and payers. The evolution from basic peak flow meters to sophisticated integrated systems, bolstered by telemedicine, has proven effective in improving outcomes for conditions like COPD and asthma. Key factors influencing market growth include payer recognition of digital monitoring in reimbursement frameworks and its integration into clinical workflows, promoting innovative pilots that leverage AI for predictive analytics and proactive patient management, ultimately leading to cost savings and better health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Respiratory Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Respiratory Devices Market Segments Analysis

Global digital respiratory devices market is segmented by product type, technology, indication, sales channel and region. Based on product type, the market is segmented into Smart Inhalers, Digital Spirometers, Wearable Respiratory Monitors, Digital Peak Flow Meters and Digital Pulse Oximeters. Based on technology, the market is segmented into Bluetooth-Enabled Devices and Wi-Fi Connected Devices. Based on indication, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease, Sleep Apnea and Others. Based on sales channel, the market is segmented into Hospital Procurement, Retail Pharmacies, Online Retail and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Respiratory Devices Market

The Global Digital Respiratory Devices market is experiencing significant growth driven by advancements in connected technologies that facilitate remote patient monitoring, data collection, and seamless integration into clinical workflows. These innovations enhance sensor accuracy and wireless connectivity, improving patient adherence and enabling proactive management of chronic respiratory conditions, thus reducing the need for episodic care. Manufacturers are capitalizing on these developments to create value-added services and forge partnerships with telehealth platforms, which broadens their market reach and fosters investment in product innovation and commercialization across various healthcare settings. This upward trajectory is crucial for the overall scaling of the market.

Restraints in the Global Digital Respiratory Devices Market

The Global Digital Respiratory Devices market faces significant challenges due to the complex and varied regulatory requirements that exist across different regions. These regulations can impede product development and market entry, ultimately constraining growth within the sector. Manufacturers are often required to invest considerable resources in generating clinical evidence, adhering to device and software standards, and addressing cybersecurity and data privacy concerns, which can extend development timelines and introduce uncertainty. Consequently, smaller companies may opt to postpone product launches or limit their target markets to alleviate the compliance burden, while health systems and payers may hesitate to adopt new technologies without clear approvals, further slowing the introduction of digital respiratory innovations to a wider patient base.

Market Trends of the Global Digital Respiratory Devices Market

The Global Digital Respiratory Devices market is witnessing a significant shift towards home connectivity and telemonitoring solutions. As remote-enabled respiratory devices become more prevalent, they facilitate ongoing patient monitoring outside traditional clinical settings, allowing clinicians to effectively track patient symptoms, medication adherence, and environmental triggers in real time. This growing integration with home networks, smartphones, and cloud technologies supports a proactive approach to patient care, leading to improved outcomes and reduced healthcare fragmentation. Consumers are increasingly demanding intuitive user interfaces and secure data-sharing capabilities, pushing manufacturers to focus on interoperability and ease of use. Consequently, care models are evolving towards preventative, home-centered management, fostering closer patient-provider collaboration and promoting equitable access to respiratory care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Digital Respiratory Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Smart Inhalers
• Digital Spirometers
• Wearable Respiratory Monitors
• Digital Peak Flow Meters
• Digital Pulse Oximeters

Global Digital Respiratory Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Bluetooth-Enabled Devices
• Wi-Fi Connected Devices

Global Digital Respiratory Devices Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Asthma
• Chronic Obstructive Pulmonary Disease
• Sleep Apnea
• Others

Global Digital Respiratory Devices Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Hospital Procurement
• Retail Pharmacies
• Online Retail
• Others

Global Digital Respiratory Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Indication, Sales Channel)
  • US
  • Canada
• Europe (Product Type, Technology, Indication, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Indication, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Indication, Sales Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Indication, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Koninklijke Philips
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adherium
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohero Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptar Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OMRON Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations